French cohort study of people with type 1 diabetes
Part of Heart & circulation, Hormones & metabolism, Immune system & allergy clinical trials.
This study follows people with type 1 diabetes in France to better understand the condition over time. It may help researchers improve future care, especially for how type 1 diabetes starts and is managed from early diagnosis onward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) are age 6 or older
- You have type 1 diabetes
- Your diabetes was diagnosed when you were more than 1 year old and 35 years old or younger
- You started insulin within the first 12 months after diagnosis
- You are enrolled in the French social security system
- You can read and speak French and can complete written informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This real-world study looks at how the Control-IQ system (an automated insulin pump with a continuous glucose monitor) affects blood sugar control and quality of life for people with type 1 diabetes in France. If you join, you will use the system as usual and fill out some questionnaires for one year.
This study looks at heart health in adults with type 1 diabetes. By joining, you'll help doctors better understand how to prevent heart problems in people like you.
This study looks at how diet affects type 2 diabetes in people who moved to France. It aims to understand your eating habits and help manage your blood sugar better.
This study tests a new automated insulin delivery system (mylife CamAPS FX) for people with type 1 diabetes. It aims to see how well the system works when paired with a Dexcom G6 continuous glucose monitor.
This study looks at how well people with diabetes understand health information and make decisions about their care. It is being done in hospitals in Reunion Island and France to help improve diabetes education and support.
This study tests whether a more personalized check-in plan can help people lower their risk of developing type 2 diabetes. You may be able to get closer guidance focused on your risk level.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.